Deriving medicines from natural product extract libraries requires capabilities most companies are unwilling to build in-house, because of the complex chemical makeup of the extracts, according to Cerylid Biosciences Ltd. The company has a library of extracts from sources throughout Southeast Asia and has developed a miniaturized and automated process for identifying single molecules active in a biological screen from among the many compounds a single extract can contain.

The company is developing a product pipeline in oncology and inflammatory diseases, but also provides its capabilities to partners, screening its extract library against their targets.